A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19

NCT04627584 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

COMBINATION_PRODUCT: MW33 injection
COMBINATION_PRODUCT: MW33 injection placebo

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.